Publication | Open Access

Phase II trial of Oxaliplatin and 5-Fluorouracil/Leucovorin combination in epithelial ovarian carcinoma relapsing within 2 years of platinum-based therapy

5-Fluorouracil/leucovorin CombinationPhase Ii TrialMedicineMetronomic TherapyEpithelial Ovarian CarcinomaGynecologyCancer TreatmentOncologyRadiation OncologyOvarian Cancer